Skip to main content

Advertisement

SpringerLink
Log in

An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Objectives

The choice of appropriate neuropsychological tests is important in evaluating the onset, severity, duration, and site of cognitive changes in postchemotherapy breast cancer survivors. This literature review is designed to evaluate and provide a summary of suitable neuropsychological tests to determine cognitive changes in breast cancer survivors.

Method

A literature search restricted to publications in English before June 2011 was performed using the following combination of keywords: “neuropsychological assessments,” “breast cancer,” “chemotherapy,” and “cognitive impairment.” Only observational studies that performed cognitive assessments on breast cancer survivors were included. The neuropsychological assessments were grouped as “objective” (traditional batteries and screening tests), “subjective,” or “computerized.”

Results

Of the 43 studies extracted, memory (88 %) and attention/concentration (88 %) are the two most commonly assessed domains. A majority (63 %) employed the use of Wechsler Adult Intelligent Scale (an objective test), while only 49 % incorporated subjective assessments to assess perceived cognitive impairment. Computerized tests received low popularity (28 %) despite their numerous advantages, which include overcoming the language- and cultural-dependent limitations of traditional objective tests.

Conclusions

In the selection of a suitable neuropsychological tool to determine the onset, severity, site, and duration of cognitive changes in breast cancer survivors, incorporation of both subjective and objective tests is essential to facilitate a comprehensive assessment. With more validation work performed in future studies, it may be feasible to employ computerized neuropsychological assessments in both clinical and research settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–708

    Article  PubMed  Google Scholar 

  2. Cheung YT, Shwe M, Tan YP, Fan G, Ng R, Chan A (2012) Cognitive changes in multiethnic Asian breast cancer patients: A focus group study. Ann Oncol. doi:10.1093/annonc/MDS1029

  3. Cheung YT, Chui WK, Chan A (2011) Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations. Crit Rev Oncol Hematol. doi:10.1016/j.critrevonc.2011.1009.1001 [Article in press]

  4. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice Cognitive Workshop. Ann Oncol 19:623–629

    Article  PubMed  CAS  Google Scholar 

  5. Vardy J, Tannock IF (2007) Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 63:183–202

    Article  PubMed  Google Scholar 

  6. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA (2010) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19:1647–1656

    Article  PubMed  Google Scholar 

  7. Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J (2008) Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psycho-Oncology 17:1189–1195

    Article  PubMed  Google Scholar 

  8. Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, van Rhijn D, Rodenhuis S, van Dam FSAM (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387–1397

    Article  PubMed  CAS  Google Scholar 

  9. Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455–2463

    Article  PubMed  Google Scholar 

  10. Hurria A, Lachs M (2007) Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Res Treat 103:259–268

    Article  PubMed  CAS  Google Scholar 

  11. Pullens MJJ, De Vries J, Roukema JA (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 19:1127–1138

    Article  PubMed  Google Scholar 

  12. Phillips K-A, Bernhard J (2003) Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst 95:190–197

    Article  PubMed  CAS  Google Scholar 

  13. Shilling V, Jenkins V, Trapala IS (2006) The (mis) classification of chemo-fog–methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 95:125–129

    Article  PubMed  Google Scholar 

  14. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9:967–982

    Article  PubMed  Google Scholar 

  15. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104:2222–2233

    Article  PubMed  Google Scholar 

  16. Strauss E, Sherman EMS, Otfried S (2006) A compendium of neuropsychological tests. Oxford University Press, New York

    Google Scholar 

  17. Scherwath A, Mehnert A, Schleimer B, Schirmer L, Fehlauer F, Kreienberg R, Metzner B, Thiel E, Zander AR, Schulz-Kindermann F, Koch UT (2006) Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol 17:415–423

    Article  PubMed  CAS  Google Scholar 

  18. Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 66:108–118

    Article  PubMed  Google Scholar 

  19. Debess J, Riis JO, Engebjerg MC, Ewertz M (2010) Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 121:91–100

    Article  PubMed  CAS  Google Scholar 

  20. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28:4434–4440

    Article  PubMed  Google Scholar 

  21. Mehlsen M, Pedersen AD, Jensen AB, Zachariae R (2009) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology 18:248–257

    Article  PubMed  Google Scholar 

  22. Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S (2009) Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology 18:134–143

    Article  PubMed  Google Scholar 

  23. Reid-Arndt SA, Yee A, Perry MC, Hsieh C (2009) Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol 27:415–434

    Article  PubMed  Google Scholar 

  24. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology 15:422–430

    Article  PubMed  Google Scholar 

  25. Wechsler D (1955) Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, Oxford

    Google Scholar 

  26. Rabin LA, Barr WB, Burton LA (2005) Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members. Arch Clin Neuropsychol 20:33–65

    Article  PubMed  Google Scholar 

  27. Camara WJ, Nathan JS, Puente AE (2000) Psychological test usage: implications in professional psychology. Prof Psychol Res Pr 31:141–154

    Google Scholar 

  28. Smith GE, Malec JF, Ivnik RJ (1992) Validity of the construct of nonverbal memory: a factor-analytic study in a normal elderly sample. J Clin Exp Neuropsychol 14:211–221

    Article  PubMed  CAS  Google Scholar 

  29. Lees-Haley PR, Greiffenstein MF, Larrabee GJ, Manning EL (2004) Methodological problems in the neuropsychological assessment of effects of exposure to welding fumes and manganese. Clin Neuropsychol 18:449–464

    Article  PubMed  Google Scholar 

  30. Flanagan DP, McGrew KS, Ortiz SO (2000) The Wechsler Intelligence Scales and Gf-Gc theory: a contemporary approach to interpretation. McGraw-Hill, Boston

    Google Scholar 

  31. Hammes JGW (1978) De Stroop Kleur–Woord Test. Handleiding, Tweede Gewijzigde Druk. [The Stroop color-word test. Manual, 2nd edn]. Swets & Zeitlinger, Lisse

    Google Scholar 

  32. Rey A (1941) L’Examen Psychologie dans Les Cas D’encephalopathie Traumatique. [The psychological examination in cases of traumatic encephalopathy]. Arch de Psychologie 23:286–228

    Google Scholar 

  33. Reitan RM (1958) Validity of the Trail Making Test As An Indicator Of Organic Brain Damage. Percept Mot Skills 8:271–286

    Google Scholar 

  34. Kulas JF, Axelrod BN (2002) Comparison of seven-subtest and Satz–Mogel short forms of the WAIS-III. J Clin Psychol 58:773–782

    Article  PubMed  Google Scholar 

  35. Ryan JJ, Lopez SJ, Werth TR (1999) Development and preliminary validation of a Satz–Mogel short form of the WAIS-III in a sample of persons with substance abuse disorders. Int J Neurosci 98:131–140

    Article  PubMed  CAS  Google Scholar 

  36. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  PubMed  CAS  Google Scholar 

  37. Randolph C, Tierney MC, Mohr E, Chase TN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20:310–319

    Article  PubMed  CAS  Google Scholar 

  38. Faust D, Fogel BS (1989) The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25–31

    Article  PubMed  CAS  Google Scholar 

  39. Vardy J, Wong K, Yi Q-L, Park A, Maruff P, Wagner L, Tannock IF (2006) Assessing cognitive function in cancer patients. Support Care Cancer 14:1111–1118

    Article  PubMed  Google Scholar 

  40. Tchen N, Juffs HG, Downie FP, Yi Q-L, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183

    Article  PubMed  Google Scholar 

  41. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701

    PubMed  CAS  Google Scholar 

  42. Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Segura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F (2010) One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 81:795–803

    Article  PubMed  Google Scholar 

  43. Minisini AM, De Faccio S, Ermacora P, Andreetta C, Fantinel R, Balestrieri M, Piga A, Puglisi F (2008) Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study. Crit Rev Oncol Hematol 67:71–79

    Article  PubMed  Google Scholar 

  44. Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP (2004) Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101:404–411

    Article  PubMed  Google Scholar 

  45. Yamada TH, Denburg NL, Beglinger LJ, Schultz SK (2010) Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci 22:48–54

    Article  PubMed  Google Scholar 

  46. Elwood DL, Griffin HR (1972) Individual intelligence testing without the examiner: reliability of an automated method. J Consult Clin Psychol 38:9–14

    Article  Google Scholar 

  47. CogState Limited (2011) CogState Research http://www.cogstate.com/go/research. Accessed 30 March 2012.

  48. Fray PJ, Robbins TW (1996) CANTAB battery: proposed utility in neurotoxicology. Neurotoxicol Teratol 18:499–504

    Article  PubMed  CAS  Google Scholar 

  49. Erlanger DM, Kaushik T, Broshek D, Freeman J, Feldman D, Festa J (2002) Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil 17:458–476

    Article  PubMed  Google Scholar 

  50. Homack S, Riccio CA (2006) Conners’ continuous performance test (2nd edn; CCPT-II). J Atten Disord 9:556–558

    Article  PubMed  Google Scholar 

  51. Feldstein SN, Keller FR, Portman RE, Durham RL, Klebe KJ, Davis HP (1999) A comparison of computerized and standard versions of the Wisconsin Card Sorting Test. Clin Neuropsychol 13:303–313

    Article  PubMed  CAS  Google Scholar 

  52. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I (2003) Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc 9:64–71

    Article  PubMed  Google Scholar 

  53. Miller EN, Satz P, Visscher B (1991) Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology 41:1608–1616

    Article  PubMed  CAS  Google Scholar 

  54. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR (1982) The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 21(Pt 1):1–16

    Article  PubMed  Google Scholar 

  55. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A (1994) Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol 16:93–104

    Article  PubMed  CAS  Google Scholar 

  56. Quesnel C, Savard J, Ivers H (2009) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116:113–123

    Article  PubMed  Google Scholar 

  57. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955–969

    Article  PubMed  Google Scholar 

  58. Shilling V, Jenkins V (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 11:6–15

    Article  PubMed  Google Scholar 

  59. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, Bishop H, Hodson N, Mitra S, Sadler G, Shah E, Stein R, Whitehead S, Winstanley J (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834

    Article  PubMed  CAS  Google Scholar 

  60. Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, Smeets A, Christiaens MR, Leemans A, Van Hecke W, Vandenberghe J, Vandenbulcke M, Sunaert S (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480–493

    Article  PubMed  Google Scholar 

  61. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB (2005) Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104:2499–2507

    Article  PubMed  Google Scholar 

  62. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA (2007) Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866–3870

    Article  PubMed  Google Scholar 

  63. Jim HSL, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB (2009) Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 115:1776–1783

    Article  PubMed  Google Scholar 

  64. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F (1993) The European Organisation for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in International clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Google Scholar 

  65. Ruzich M, Ryan B, Owen C, Delahunty A, Stuart-Harris R (2007) Prospective evaluation of cognitive function in patients with early breast cancer receiving adjuvant chemotherapy. Asia Pac J Clin Oncol 3:123–133

    Article  Google Scholar 

  66. Schagen SB, Hamburger HL, Muller MJ, Boogerd W, van Dam FSAM (2001) Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol 51:159–165

    Article  PubMed  CAS  Google Scholar 

  67. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218

    Article  PubMed  Google Scholar 

  68. Skaali T, Foss SD, Dahl AA (2011) A prospective study of cognitive complaints in patients with testicular cancer. Clin Genitourin Cancer 9:6–13

    Article  PubMed  Google Scholar 

  69. Gan HK, Bernstein LJ, Brown J, Ringash J, Vakilha M, Wang L, Goldstein D, Kim J, Hope A, O’Sullivan B, Waldron J, Abdul Razak AR, Chen EX, Siu LL (2011) Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 81:126–134

    Article  PubMed  Google Scholar 

  70. Juergens A, Pels H, Rogowski S, Fliessbach K, Glasmacher A, Engert A, Reiser M, Diehl V, Vogt-Schaden M, Egerer G, Schackert G, Reichmann H, Kroschinsky F, Bode U, Herrlinger U, Linnebank M, Deckert M, Fimmers R, Schmidt-Wolf IGH, Schlegel U (2010) Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol 67:182–189

    Article  PubMed  CAS  Google Scholar 

  71. Taillibert S, Voillery D, Bernard-Marty C (2007) Chemobrain: is systemic chemotherapy neurotoxic? Curr Opin Oncol 19:623–627

    Article  PubMed  Google Scholar 

  72. Schatz P, Browndyke J (2002) Applications of computer-based neuropsychological assessment. J Head Trauma Rehabil 17:395–410

    Article  PubMed  Google Scholar 

  73. Saykin AJ, Ahles TA, McDonald BC (2003) Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 8:201–216

    Article  PubMed  Google Scholar 

  74. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123:819–828

    Article  PubMed  CAS  Google Scholar 

  75. Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YKK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123:25–34

    Article  PubMed  Google Scholar 

  76. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356

    Article  PubMed  Google Scholar 

  77. Biglia N, Moggio G, Peano E, Sgandurra P, Ponzone R, Nappi RE, Sismondi P (2010) Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. J Sex Med 7:1891–1900

    Article  PubMed  Google Scholar 

  78. Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G (2009) Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc 15:951–962

    Article  PubMed  Google Scholar 

  79. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Munzel K (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913

    Article  PubMed  CAS  Google Scholar 

  80. Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock IF (2006) Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psycho-Oncology 15:921–930

    Article  PubMed  Google Scholar 

  81. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA (2004) ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer 101:466–475

    Article  PubMed  Google Scholar 

  82. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299

    Article  PubMed  CAS  Google Scholar 

  83. Servaes P, Verhagen CA, Bleijenberg G (2002) Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 95:2017–2026

    Article  PubMed  Google Scholar 

  84. Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 4:61–66

    Article  Google Scholar 

  85. Kreukels BP, van Dam FS, Ridderinkhof KR, Boogerd W, Schagen SB (2008) Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer 8:80–87

    Article  PubMed  CAS  Google Scholar 

  86. Gottschalk LA, Holcombe RF, Jackson D, Bechtel RJ (2003) The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. Methods Find Exp Clin Pharmacol 25:117–122

    Article  PubMed  CAS  Google Scholar 

  87. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650

    Article  PubMed  CAS  Google Scholar 

  88. Falleti MG, Maruff P, Collie A, Darby DG (2006) Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test–retest intervals. J Clin Exp Neuropsychol 28:1095–1112

    Article  PubMed  Google Scholar 

  89. French CC, Beaumont JG (1987) The reaction of psychiatric patients to computerized assessment. Br J Clin Psychol 26:267–278

    Article  PubMed  Google Scholar 

  90. Collie A, Maruff P, McStephen M, Darby DG (2003) Psychometric issues associated with computerised neuropsychological assessment of concussed athletes. Br J Sports Med 37:556–559

    Article  PubMed  CAS  Google Scholar 

  91. Collie A, Maruff P (2003) Computerised neuropsychological testing. Br J Sports Med 37:2–3

    Article  PubMed  CAS  Google Scholar 

  92. Collie A, Maruff P, Makdissi M, McCrory P, McStephen M, Darby D (2003) CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med 13:28–32

    Article  PubMed  Google Scholar 

  93. Conners CK, Staff M (2000) Conners’ Continuous Performance Test (CPT II) computer programs for Windows technical guide and software manual. Multi-Health Systems, North Tonawanda

    Google Scholar 

  94. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  PubMed  CAS  Google Scholar 

  95. Cimprich B, Visovatti M, Ronis DL (2011) The Attentional Function Index—a self-report cognitive measure. Psycho-Oncology 20:194–202

    Article  PubMed  Google Scholar 

  96. Goldberg D, Williams P (1988) A user’s guide to the general health questionnaire. NFER-Nelson, Windsor

    Google Scholar 

  97. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579

    PubMed  CAS  Google Scholar 

  98. Duff K, Beglinger LJ, Schoenberg MR, Patton DE, Mold J, Scott JG, Adams RL (2005) Test–retest stability and practice effects of the RBANS in a community dwelling elderly sample. J Clin Exp Neuropsychol 27:565–575

    Article  PubMed  Google Scholar 

  99. Nelson HE (1982) National Adult Reading Test (NART): test manual. NFER Nelson, Windsor

    Google Scholar 

  100. Blair JR, Spreen O (1989) Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsychol 3:129–136

    Google Scholar 

  101. Crawford JR, Stewart LE, Besson JAO, Parker DM, De Lacey G (1989) Prediction of WAIS IQ with the National Adult reading test: Cross-validation and extension. Br J Clin Psychol 28:267–273

    Google Scholar 

  102. Raguet ML, Campbell DA, Berry DTR, Schmitt FA, Smith GT (1996) Stability of intelligence and intellectual predictors in older persons. Psychol Assess 8: 154–160

    Google Scholar 

  103. Mitrushina M, Satz P (1991) Effect of repeated administration of a neuropsychological battery in the elderly. J Clin Psychol 47:790–801

    Article  PubMed  CAS  Google Scholar 

  104. Shapiro AM, Benedict RH, Schretlen D, Brandt J (1999) Construct and concurrent validity of the Hopkins Verbal Learning Test—revised. Clin Neuropsychol 13:348–358

    Article  PubMed  CAS  Google Scholar 

  105. Kaplan EF, Goodglass H, Weintraub S (2001) The Boston naming test, 2nd edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  106. Flanagan JL, Jackson ST (1997) Test–retest reliability of three aphasia tests: performance of non-brain-damaged older adults. J Commun Disord 30:33–42

    Article  PubMed  CAS  Google Scholar 

  107. Mitrushina M, Satz P (1995) Repeated testing of normal elderly with the Boston naming test. Aging 7:123–127

    Google Scholar 

  108. Ross TP, Calhoun E, Cox T, Wenner C, Kono W, Pleasant M (2007) The reliability and validity of qualitative scores for the Controlled Oral Word Association Test. Arch Clin Neuropsychol 22:475–488

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Blk S4, Singapore, 117543, Singapore

    Yin Ting Cheung, Earl Hsien-Jie Tan & Alexandre Chan

  2. Department of Pharmacy, National Cancer Centre Singapore, Singapore, Singapore

    Alexandre Chan

Authors
  1. Yin Ting Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Earl Hsien-Jie Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandre Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexandre Chan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheung, Y.T., Tan, E.HJ. & Chan, A. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Support Care Cancer 20, 1361–1375 (2012). https://doi.org/10.1007/s00520-012-1445-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1445-4

Keywords

Search

Navigation